The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials

Background: Randomized controlled trials (RCTs) are the gold standard for treatment efficacy, but foot and ankle RCTs are often small or inconsistent. The Fragility Index (FI) evaluates the stability of significant findings. This study assessed the fragility of RCT outcomes for Achilles tendon patho...

Full description

Saved in:
Bibliographic Details
Main Authors: Omkar S. Anaspure BA, Shiv Patel BA, Anthony N. Baumann DPT, Andrew Newsom BS, Albert T. Anastasio MD, Annunziato Amendola MD
Format: Article
Language:English
Published: SAGE Publishing 2024-11-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/24730114241300160
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846161428148387840
author Omkar S. Anaspure BA
Shiv Patel BA
Anthony N. Baumann DPT
Andrew Newsom BS
Albert T. Anastasio MD
Annunziato Amendola MD
author_facet Omkar S. Anaspure BA
Shiv Patel BA
Anthony N. Baumann DPT
Andrew Newsom BS
Albert T. Anastasio MD
Annunziato Amendola MD
author_sort Omkar S. Anaspure BA
collection DOAJ
description Background: Randomized controlled trials (RCTs) are the gold standard for treatment efficacy, but foot and ankle RCTs are often small or inconsistent. The Fragility Index (FI) evaluates the stability of significant findings. This study assessed the fragility of RCT outcomes for Achilles tendon pathology (ATP) interventions. Methods: This systematic review queried PubMed up to May 14, 2024, for RCTs on ATP interventions. RCTs with significant binary outcomes were included. Two reviewers assessed eligibility, extracted data, calculated FIs, and evaluated risk of bias. Frequency-weighted means were used for narrative synthesis. Results: Eleven RCTs with 4506 patients (mean cohort size: 409.64 ± 160.54) and a mean age of 36.97 ± 13.51 years (n = 4356; 96.67%) were included, covering 24 binary outcomes. The median FI across all outcomes was 3 (interquartile range 1-4; mean 3.92), indicating that changing the outcome of just a few patients could shift a study’s results from statistically significant to nonsignificant. Trials having an FI ≤3 comprised 58.33%. Three outcomes (12.5%) had an FI of zero after recalculating P values using the two-sided Fisher exact test. Half of the outcomes were robust. No RCT reported FIs or adjusted significance for multiple testing. Most studies (81.82%) performed 2 or more statistical tests, with an average of 30.81 ± 41.28 P values reported per study. The overall risk of bias was low in 1 study (9.09%) and moderate in 7 (63.64%). Most studies had low risk of bias in randomization (72.73%) and missing outcome data (90.91%). Conclusion: The FI assesses the fragility of statistically significant binary results, revealing that many ATP RCTs have fragile outcomes due to small sample sizes. A median FI of 3 means that changing the outcome of 3 patients could shift a study’s results from statistically significant to nonsignificant.
format Article
id doaj-art-cebd0cf9beff4f0b990b906a8f4999cf
institution Kabale University
issn 2473-0114
language English
publishDate 2024-11-01
publisher SAGE Publishing
record_format Article
series Foot & Ankle Orthopaedics
spelling doaj-art-cebd0cf9beff4f0b990b906a8f4999cf2024-11-21T08:06:21ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142024-11-01910.1177/24730114241300160The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized TrialsOmkar S. Anaspure BA0Shiv Patel BA1Anthony N. Baumann DPT2Andrew Newsom BS3Albert T. Anastasio MD4Annunziato Amendola MD5Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USADepartment of Rehabilitation Services, University Hospitals, Cleveland, OH, USACollege of Medicine, Northeast Ohio Medical University, Rootstown, OH, USADepartment Orthopedic Surgery, Duke University, Durham, NC, USADepartment Orthopedic Surgery, Duke University, Durham, NC, USABackground: Randomized controlled trials (RCTs) are the gold standard for treatment efficacy, but foot and ankle RCTs are often small or inconsistent. The Fragility Index (FI) evaluates the stability of significant findings. This study assessed the fragility of RCT outcomes for Achilles tendon pathology (ATP) interventions. Methods: This systematic review queried PubMed up to May 14, 2024, for RCTs on ATP interventions. RCTs with significant binary outcomes were included. Two reviewers assessed eligibility, extracted data, calculated FIs, and evaluated risk of bias. Frequency-weighted means were used for narrative synthesis. Results: Eleven RCTs with 4506 patients (mean cohort size: 409.64 ± 160.54) and a mean age of 36.97 ± 13.51 years (n = 4356; 96.67%) were included, covering 24 binary outcomes. The median FI across all outcomes was 3 (interquartile range 1-4; mean 3.92), indicating that changing the outcome of just a few patients could shift a study’s results from statistically significant to nonsignificant. Trials having an FI ≤3 comprised 58.33%. Three outcomes (12.5%) had an FI of zero after recalculating P values using the two-sided Fisher exact test. Half of the outcomes were robust. No RCT reported FIs or adjusted significance for multiple testing. Most studies (81.82%) performed 2 or more statistical tests, with an average of 30.81 ± 41.28 P values reported per study. The overall risk of bias was low in 1 study (9.09%) and moderate in 7 (63.64%). Most studies had low risk of bias in randomization (72.73%) and missing outcome data (90.91%). Conclusion: The FI assesses the fragility of statistically significant binary results, revealing that many ATP RCTs have fragile outcomes due to small sample sizes. A median FI of 3 means that changing the outcome of 3 patients could shift a study’s results from statistically significant to nonsignificant.https://doi.org/10.1177/24730114241300160
spellingShingle Omkar S. Anaspure BA
Shiv Patel BA
Anthony N. Baumann DPT
Andrew Newsom BS
Albert T. Anastasio MD
Annunziato Amendola MD
The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials
Foot & Ankle Orthopaedics
title The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials
title_full The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials
title_fullStr The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials
title_full_unstemmed The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials
title_short The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials
title_sort fragility of statistically significant binary outcomes for treating achilles tendinopathy a systematic review of randomized trials
url https://doi.org/10.1177/24730114241300160
work_keys_str_mv AT omkarsanaspureba thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT shivpatelba thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT anthonynbaumanndpt thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT andrewnewsombs thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT alberttanastasiomd thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT annunziatoamendolamd thefragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT omkarsanaspureba fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT shivpatelba fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT anthonynbaumanndpt fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT andrewnewsombs fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT alberttanastasiomd fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials
AT annunziatoamendolamd fragilityofstatisticallysignificantbinaryoutcomesfortreatingachillestendinopathyasystematicreviewofrandomizedtrials